What We're Reading: Page 315
Industry reads hand-picked by our editors
Jan 31, 2017
-
Reuters
Trump to meet Novartis CEO, other pharma bosses on Tuesday
-
The Wall Street Journal
Rep. Tom Price got privileged, discounted offer on biomedical stock, company says
-
Bloomberg
Natco Pharma rallies as U.S. judge invalidates Teva’s Copaxone patents
-
CNN
After trial death and before Trump change, a call for drug approval reform
Jan 30, 2017
-
Bloomberg
Old cancer drug gets 1,227% price hike in frugal U.K.
-
CNBC
Danish drugmaker Novo Nordisk bets $145 mln on post-Brexit UK science
-
Kaiser Health News
Getting patients hooked on an opioid overdose antidote, then raising the price
-
Chemical & Engineering News
The year in new drugs
Jan 27, 2017
-
Bloomberg BNA
Will Trump’s hiring freeze put FDA’s new cures jobs on ice?
-
Politico
Cuomo's pharma proposals face uncertain future
-
Regulatory Focus
Pharma companies take issue with FDA proposal to overhaul nonclinical study regulations
-
Bloomberg
Hedge funds strike paydirt on Actelion deal after tracking J&J's jet
Jan 26, 2017
Jan 25, 2017
-
The Hill
2016 FDA drug approval numbers — what can Trump conclude?
-
EP Vantage
Life for kinase inhibitors in an immuno-oncology world
-
Crain's Chicago Business
How to make sure participants make it to clinical trials? Enter Lyft
-
Science
The Hollywood analogy
Jan 24, 2017
-
The New York Times
The fight Trump faces over drug prices
-
The Associated Press
Maine bill seeks to curtail drug company payments to doctors
-
Forbes
Keep politics out of science, says departing FDA chief
-
Quartz
A US town with a population of 105,000 is suing a drugmaker for ignoring illegal OxyContin sales
Jan 23, 2017
-
Kaiser Health News
Trump’s HHS pick favored drugmakers, device makers and doctors
-
The Telegraph
Small drug companies grow as big pharma outsources
-
Reuters
Egypt's military to enter pharmaceutical industry
-
The Boston Globe
How a biotech startup rose, and then fell
Previous
